Screener
Eli Lilly LLY AOCI
AOCI at other companies
Other financials
Where this comes from
Reported directly by Eli Lilly in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The source filing: Eli Lilly’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 2:40 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000059478-26-000081
FAQ
- What is Eli Lilly's AOCI?
- Eli Lilly (LLY) reported AOCI of -$2.76B in Q2 2026.
- How has Eli Lilly's AOCI changed year-over-year?
- Eli Lilly's AOCI increased by 25.7% year-over-year, from -$3.72B to -$2.76B.
- What is the long-term trend for Eli Lilly's AOCI?
- Over 5 years (2020 to 2025), Eli Lilly's AOCI has grown at a -15.0% compound annual growth rate (CAGR), from -$6.5B to -$2.88B.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.
Ask your AI about Eli Lilly's aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude